A complete listing of currently available online programs is provided below. To view course materials click an available viewing format provided with each listing (PDF, HTML, Interactive). To access online exams and claim credit you must be registered and logged in. To add courses to your "MyAR Archives" user account select the "Add To Cart" button provided with each course title and follow the prompts.
|
* Advanced MRI Safety Training For Healthcare Professionals (4th Edition): Level 2 MR Personnel
|
|
Released:
April 22, 2020
•Expires:
April 30, 2022
|
CE credits:
3.0
• Cost:
$50.00
|
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
This program reviews fundamental MRI safety information and meets the annual training recommendations from the American College of Radiology. Importantly, MRI facilities must now comply with the revised requirements for diagnostic imaging from The Joint Commission and document that MRI technologists participate in ongoing education that includes annual training on safe MRI practices in the MRI environment. Notably, Advanced MRI Safety Training for Healthcare Professionals, Level 2 MR Personnel covers each MRI safety topic specified by The Joint Commission, as well as many additional subjects that will expand the knowledge-base of healthcare professionals involved with MRI technology.
With 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Advanced MRI Safety Training for Healthcare Professionals (4th Edition), Level 2 MR Personnel is a 2 hour and 45 minute program that is divided into three different sections.
Educational Objectives
-
Understand the safety issues related to MRI.
-
Describe the bioeffects associated with the static magnetic field, time-varying magnetic fields, and radiofrequency fields.
-
Present guidelines that prevent projectile-related accidents.
-
Describe polices that avoid issues related to acoustic noise.
-
Review procedures that prevent burns associated with MRI.
-
Explain and demonstrate appropriate pre-MRI screening procedures.
-
Identify techniques to manage patients with claustrophobia, anxiety, or emotional distress.
-
Describe guidelines to handle medical emergencies in the MRI setting.
-
Understand the safety considerations for gadolinium-based contrast agents.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
|
* Basic MRI Safety Training (4th Edition): Level 1 MR Personnel
|
|
Released:
April 01, 2021
•Expires:
April 30, 2023
|
CE credits:
1.0
• Cost:
$30.00
|
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
Individuals entering the magnetic resonance imaging (MRI) environment, whether on a regular or infrequent basis, must be properly trained to ensure their safety, the protection of patients, and the security of other facility staff members. This program, Basic MRI Safety Training, Level 1 MR Personnel accomplishes the initial training that is necessary to ensure safety in the unique setting associated with the MRI system. It includes information pertaining to MRI technology, describes common hazards and unique dangers associated with the MRI setting, and presents vital recommendations and guidelines to prevent accidents and injuries. Importantly, this program provides the fundamental MRI safety information for Level I MR Personnel recommended by the American College of Radiology and may be utilized by individuals preparing for safety training as Level 2 MR Personnel.
With more than 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Educational Objectives
-
Appreciate the importance of MRI
-
Identify the hazards associated with MRI
-
Understand the screening process
-
Describe steps to prevent accidents and injuries
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
|
* Introduction To MRI Safety - Updated Edition
|
|
Released:
April 04, 2017
•Expires:
April 30, 2023
|
CE credits:
0
• Cost:
$15.00
|
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
This program provides an overview of MRI safety information that is intended for non-clinical staff members who regularly work in the MRI environment or who may occasionally work in this area as part of their responsibilities. Anyone who enters the MRI environment, even infrequently, must be properly trained to ensure their safety, the safety of patients, and other facility staff members
After completion of a short online exam, with a passing score of 70% or higher, this program provides a Statement of Participation.
With more than 30 years of experience in the field of MRI, the author of the best selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creater of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Educational Objectives
-
Appreciate the importance of MRI
-
Identify the certain hazards associated with MRI technology
-
Describe steps to prevent accidents and injuries related to ferromagnetic objects
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
|
Cardiovascular Imaging: Complex Applications in Cardiac CT and CT Angiography
|
|
Released:
June 01, 2021
•Expires:
June 01, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Richard Hallett, MD
|
Often there is lack of knowledge amongst imaging professionals regarding IV contrast dynamics and the relationship between contrast injection, observed enhancement, and scan acquisition timing. The design of appropriate imaging protocols leads to effective and consistent cardiovascular exams; especially when applied to complex clinical scenarios.
This CME/CE accredited program will review contrast-saline dynamics and discuss rational protocol design for cardiac and vascular CT angiography. Effective cardiovascular imaging protocols, utilizing multiple CT injector platforms to achieve optimal imaging, will be reviewed. We invite you to join Dr. Richard Hallett for a comprehensive discussion and case study review of this important topic.
Following the presentation questions from the audience were addressed in a moderated Q&A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Understand the relationship between bolus contrast media injection and observed enhancement.
-
Implement methods to design rational contrast injection / scan acquisition protocols.
-
Review various models of CT contrast injectors and discuss benefits, limitations, and injection protocol adjustments for each.
-
Apply customized contrast-saline injection / scan principles to complex cardiovascular disease cases.
Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
|
Contrast-enhanced Ultrasound of Renal Masses
|
|
Released:
November 01, 2020
•Expires:
October 31, 2022
|
CE credits:
1
• Cost:
$0.00
|
|
Faculty:
Applied Radiology
|
Jack Bennett, Cynthia Peterson, MPH, RDMS, RVT; Richard G. Barr MD, PhD
Ultrasound (US) is often the initial imaging modality for evaluation of renal diseases. Non-enhanced US faces limitations in the assessment of focal renal masses and complex cysts. Contrast-enhanced ultrasound (CEUS) on the kidneys can overcome these shortcomings.
There are several advantages of CEUS over contrast-enhanced CT or contrast-enhanced MRI. These include the fact that the narrow US beam allows for improved visualization of vascularity in small structures such as septations or small mural nodules; high temporal resolution with real time assessment of vascularity; lack of radiation; and no renal impairment.
Excluding inflammatory masses, vascular abnormalities and pseudotumors, most solid enhancing renal masses are malignant. Complicated cystic lesions with enhancing soft tissue components, excluding the actual cyst wall, are malignant. Using enhancement pattern, renal masses can be characterized with high sensitivity and specificity
Available for SA-CME Credit. To receive SA–CME credit, you must complete the post exam and review the discussion and references provided with the exam results.
|
|
|
|
|
COVID-19 Facts, Findings, and Imaging Manifestations
|
|
Released:
July 02, 2020
•Expires:
July 02, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR | W. Christopher Baughman, MD
|
In this Expert Forum, Dr. Lawrence Tanenbaum and Dr. William Baughman provide a comprehensive review of what the COVID-19 virus is, how it’s transmitted, as well as, how it presents clinically on various imaging modalities. Additionally, a review of “real-world” clinical findings of COVID positive patients, who present with additional symptoms that are manifested from coronavirus will be shared. Following the presentations, a moderated discussion will take place where questions from the audience will be addressed.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the clinical manifestations and impact of COVID
-
Describe the clinical findings and presentations of COVID
-
Differentiate the image findings of COVID positive patients
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|
|
MR Contrast Agents: A Review of the Current Agents & Their Safety Profile
|
|
Released:
December 01, 2020
•Expires:
December 01, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR
|
Today, with such a wide selection of gadolinium-based contrast agents available to choose from; imaging professionals must be aware of the chemical make-up when selecting a MR agent for a particular exam.
Join us for a live CME accredited webinar with Lawrence N. Tanenbaum, MD, FACR, who will provide a review of the currently available FDA-approved MR contrast agents and their safety profiles. Following his talk, Dr. Tanenbaum will be available for a live Q&A, where your questions are encouraged.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Discuss the available FDA-approved contrast agents in the US market.
-
Review the chemical structure, indications, and safety profile of these agents.
-
Develop a better understanding of how selection of contrast can affect patient outcomes.
Supported through an unrestricted educational grant from GE Healthcare
|
|
|
|
|
MR Contrast Selection & Utilization in Pediatric & Neonatal Patients
|
|
Released:
November 22, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Chetan C. Shah, MD, MBA
|
In MR Imaging, a careful review of the safety criteria for the selection of a Gadolinium-based Contrast Agents (GBCAs) should be considered for pediatric and neonatal patients. The program will provide a comprehensive review of the supporting research that addresses Gadolinium selection in this special patient population. Both chronic and long-term effects of GBCAs will be discussed.
As a Pediatric Neuroradiologist, Dr. Shah is uniquely qualified to share his experience which includes a discussion of risk vs benefits, supported by practical protocols for the administration of MR contrast; including limiting the amount of contrast given to patients that may receive several lifetime doses. Following the presentation, the audience is invited to join Dr. Shah for an interactive Q & A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the differences between available MR contrast agents and any associated adverse events
-
Improve clinical management decisions about when to administer MR contrast (risk vs benefit)
-
Apply FDA guidelines regarding MRI contrast agents to clinical practice.
Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
|
Part 1 | The Foundation of Integrating DBT Into Your Practice
|
|
Released:
October 06, 2020
•Expires:
October 31, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Laurie L. Fajardo, MD
|
In this program Dr. Laurie Fajardo shares her experience with the set-up and use of digital breast tomosynthesis (DBT) in clinical practice. Participants will hear about system design, the impact on clinical performance, and how to best manage recall rates. In addition through carefully selected cases, Dr. Fajardo will share her approach to image interpretation and how one can manage DBT workflow effectively.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the technology behind digital breast tomosynthesis (DBT).
-
Describe the impact DBT has on clinical performance.
-
Implement an approach to DBT interpretation.
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|
|
Part 2 | The Application of Integrating DBT Into Your Practice
|
|
Released:
October 13, 2020
•Expires:
October 31, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Laurie L. Fajardo, MD
|
In this second of a 3 Part Series, Dr. Laurie Fajardo discusses the benefits of digital breast tomosynthesis (DBT) for detecting and diagnosing breast cancer and things to consider when planning or implementing DBT into breast imaging practices.
Dr. Fajardo discusses the importance of radiation dose reduction with synthetic 2D, reviews the published literature on the performance of synthetic 2D mammography, and shares how DBT can impact data storage and network data transmission across your PACS and enterprise system.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Describe the efficacy of synthetic 2D from DBT.
-
Implement procedures for managing DBT data volumes and workflow.
-
Develop an approach to interpreting DBT images.
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|
|
Part 3 | DBT, Breast Density and Artificial Intelligence
|
|
Released:
October 20, 2020
•Expires:
October 31, 2022
|
CE credits:
1.5
• Cost:
$0.00
|
|
Faculty:
Laurie L. Fajardo, MD
|
In this final segment of this 3-part series, Dr. Laurie Fajardo addresses the radiologist’s challenges associated with dense breast imaging and interpretation through discussion and case presentation of interval breast cancer. This includes issues associated with assigning breast cancer risk to breast density and qualitative versus quantitative methods for assessing, and reporting breast density and risk assessment.
Further Dr. Fajardo will discuss how to incorporate breast cancer risk assessment into your breast imaging practice and closes the program with a discussion on the current impact of Artificial Intelligence on breast imaging and how it can enhance workflow.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Articulate issues associated with assessing and reporting breast density and its associated cancer risk.
-
Explain the benefits of incorporating comprehensive risk assessment into breast imaging practices.
-
Implement the use of artificial intelligence to enhance breast imaging practice workflow and performance.
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|
|
Pregnancy-associated Breast Cancer and Other Breast Disease: A Radiologic Review
|
|
Released:
September 01, 2020
•Expires:
August 31, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Applied Radiology
|
Andrew Ong, MD; Lisa A Mullen, MD; Susan C. Harvey, MD
Pregnancy associated breast cancer (PABC) is a subset of breast cancer that is typically diagnosed at more advanced stages and carries a worse prognosis. The physiological breast changes that occur during pregnancy and lactation can often make clinical and radiological evaluation difficult.
Ultrasound is the primary imaging modality in the evaluation of pregnancy associated breast lesions with high sensitivity and lack of radiation. Mammography is generally considered safe during pregnancy and lactation and may also be used to assess for PABC. Dynamic contrast enhanced breast MRI is not recommended during pregnancy; however, it may safely be performed in lactating women to evaluate extent of disease or for high risk screening.
This article reviews appropriate imaging evaluation of the pregnant or lactating woman, and showcases the imaging features of benign and malignant lesions occurring during pregnancy and lactation. Many benign lesions, including fibroadenoma and lactating adenoma, can mimic malignancy. New or growing solid masses occurring during pregnancy and lactation should be further evaluated with imaging and biopsy, to avoid a delay in a potential cancer diagnosis.
Available for SA-CME Credit. To receive SA–CME credit, you must complete the post exam and review the discussion and references provided with the exam results.
|
|
|
|
|
PSMA Imaging: Current Status & Prospects
|
|
Released:
October 29, 2020
•Expires:
October 31, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Jeremie Calais, MD, MSc | Jeffrey R. Karnes, MD | Oliver Sartor, MD
|
This educational webinar features a panel of experts from Nuclear Medicine, Urology and Oncology, who are involved in the diagnosis and management of Prostate Cancer. By understanding the benefits of PSMA imaging, a Urologist’s timely referral can positively impact the patient’s journey and ultimately their quality of life. The clinical benefits of a prompt and accurate diagnosis of Prostate CA, using PSMA-11 PET/CT, will be reviewed by the faculty.
Upon completion of this CME activity the healthcare provider should be able to:
-
Discuss the clinical benefits of PSMA Imaging for the diagnosis and management of prostate cancer
-
Describe patient considerations for 68GA PSMA-11 PET/CT
-
Articulate the clinical implications supporting the timely diagnosis of prostate cancer
-
Implement guidelines of when to order 68GA PSMA-11 vs other imaging modalities (Bone scan, CT, MRI)
-
Implement PSMA Imaging practice considerations to improve outcomes and patient management
This program is made possible through an unrestricted educational grant from Telix Pharmaceuticals
|
|
|
|
|
The Role of Digital Breast Tomosynthesis in Breast Cancer Screening, Diagnosis, and Continued Patient Management
|
|
Released:
August 01, 2020
•Expires:
July 31, 2022
|
CE credits:
2.0
• Cost:
$0.00
|
|
Faculty:
Applied Radiology
|
Digital breast tomosynthesis, also known as 3D DBT first entered the clinical arena in 2011 when the FDA approved its use. Multiple studies have since shown that tomosynthesis is effective in both the screening and the diagnostic setting. This technology has quickly emerged as a practice-changing standard by increasing both sensitivity and specificity, thereby improving breast cancer detection and the clinical accuracy of mammograms.
This Expert Forum educational program focuses on the impact of digital breast tomosynthesis and the role it plays in all aspects of breast screening. In this program, you will hear from an expert panel consisting of four (4) healthcare professionals from various specialties; who are all involved in the diagnosis, treatment and care of breast cancer patients and who will share their clinical insights and experience.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Discuss the importance of breast screening mammography.
-
Compare the differences between 2D and 3D mammography.
-
Explain how the use of 3D DBT will benefit their patients.
-
Increase the collaboration between radiologists and referring physicians.
-
Implement best practices for concise communication across the continuum of care.
Supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|